Delivery Order SPE2DX15D9348-SPE2DX24FBECC
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$74K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred forty-six thousand five hundred fifty dollars and eight cents ($146,550.08) by the Defense Logistics Agency. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group...
The Defense Logistics Agency (DLA) awarded a $55,580.49 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under DLA's SPE2DB Pharmaceutical Prime Vendor program, is to provide the pharmaceutical product Trikafta 100-50-75 mg/150 mg with an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group holds a large, single-award indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
The U.S. Defense Logistics Agency (DLA) awarded a $18,474.02 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is not associated with a set-aside designation, is for the delivery of the drug Trikafta 50-25-37.5 mg/75 mg. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program, which allows the agency to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $53,193.27 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Trikafta, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG tablets to support the medical supply needs of military facilities. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle (IDV) contract SPE2DB with DLA, valued at up to $4,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is under the SPE2DB program, a multi-year indefinite delivery vehicle DMS Pharmaceutical Group holds with DLA valued at up to $4,999,999 for a broad range of pharmaceutical products. This order is for TRIKAFTA, a prescription medication, with an ultimate completion date of April 3,...
The Defense Logistics Agency (DLA) awarded a $51,136.76 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta 100-50-75 mg/75 mg packets, a specialized pharmaceutical product, with a performance period through June 26, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, with a period of performance through April 1, 2024, is for the delivery of the pharmaceutical product Trikafta 100-50-75 mg/150 mg. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB22D9102 with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $55,580.49, is a firm fixed-price delivery order for the pharmaceutical product Trikafta (80-40-60mg/59.5mg, 14-count packets). DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...